Extension without change of a currently approved collection
No
Regular
12/28/2020
Requested
Previously Approved
36 Months From Approved
01/31/2021
12,156
12,156
2,342
2,342
147,817
147,817
Title 21 U.S.C. 827 requires
controlled substance manufacturers and distributors to make
periodic reports to the DEA regarding the sale, delivery, and other
disposal of certain controlled substances. The implementing
regulations are found at 21 CFR 1304.33. The Single Convention on
Narcotic Drugs, 1961, and the Convention on Psychotropic
Substances, 1971, impose certain reporting obligations on the
United States, and aggregate data from Form 333s are provided to
the International Narcotics Control Board to meet those
obligations.
US Code:
21
USC 827 Name of Law: Records and Reports of Registrants
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.